Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study

Detalles Bibliográficos
Autores principales: Blaha, V, Margoczy, R, Petrov, I, Postadzhiyan, A, Raslova, K, Rosolova, H, Bridges, I, Dhalwani, NN, Zachlederova, M, Ray, KK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
27th Annual Meeting of the ISCP
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316339/
https://www.ncbi.nlm.nih.gov/pubmed/37405342
http://dx.doi.org/10.15420/ecr.2023.18.PO19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316339/
https://www.ncbi.nlm.nih.gov/pubmed/37405342
http://dx.doi.org/10.15420/ecr.2023.18.PO19

Ejemplares similares